|
Video: What is a Stock Split?
|
|
Renalytix is an artificial intelligence-enabled in vitro diagnostics company, focused on supporting clinical management of kidney disease. KidneyIntelX, Co.'s diagnostic platform, employs a proprietary artificial intelligence-enabled algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems, to generate a patient risk score. This patient risk score enables prediction of progressive kidney function decline in chronic kidney disease, allowing physicians and healthcare systems to support the allocation of treatments and clinical resources to patients at highest risk. According to our Renalytix stock split history records, Renalytix has had 0 splits. | |
|
Renalytix (RNLX) has 0 splits in our Renalytix stock split history database.
Looking at the Renalytix stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Renalytix shares, starting with a $10,000 purchase of RNLX, presented on a split-history-adjusted basis factoring in the complete Renalytix stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/20/2020 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$13.60 |
|
End price/share: |
$0.63 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-95.38% |
|
Average Annual Total Return: |
-55.75% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$462.53 |
|
Years: |
3.77 |
|
|
|
|
|